Abstract
To investigate the possible role of genomic aberrations of chromosome 9p21 in the tumorigenesis of human renal cell carcinoma (RCC), 40 sporadic RCCs were studied using PCR analyses. The tumours were predominantly low stage and low grade. Loss of heterozygosity (LOH) was observed in nine of 39 informative cases, but no homozygous deletion was noticed. Hypermethylation of the promoter region of p16 occurred in eight of the 40 RCCs. No correlation was found between hypermethylation of the p16 gene and LOH on 9p21. A similar level of LOH and methylation was observed in the 40 RCCS regardless of histology, grade and stage. These results suggest that inactivation of p16 and the possibility of other unknown tumour suppresser genes located on other chromosomes could be involved in the pathogenesis of RCC.
Similar content being viewed by others
References
Cairns P, Tokino K, Eby Y, Sidransky D (1995) Location of tumour suppresser loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res 55: 224
Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W.(1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet11: 210
Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D (1994) Rates of p16(MTS1) mutations in primary tumours with 9p loss. Science 265: 415
Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee WC, Altomare DA, Nobori T, Olapade OI, Bucker AJ, Testa JR (1994) p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 54: 5547
Costello JF, Berger MS, Huang HS, Cavenee WK (1996) Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 56: 2405
Foster K, Crossey PA, Cairns P, Hetherington JW, Richards FM, Jones MH, Bentley E, Affara NA, Ferguson-Smith MA, Maher ER (1994) Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer 69: 230
Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655
Gonzales-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumour suppressor gene in normal and transformed human tissues correlates with gene silencing, Cancer Res 55: 4531
Gonzalgo ML, Bender CM, You EH, Glendening JM, Flores JF, Walker GJ, Hayward NK, Jones PA, Fountain JW (1997) Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumours. Cancer Res 57: 5336
Herbert J, Cayuela JM, Berkeley J, Sigaux F (1994) Candidate suppressor-suppressor genes MTS1 (p16 INK4a) and MTS2 (p15 INK4b) display frequent homozygous deletions in primary cells from T- but not B-cell lineage acute lymphocytic leukaemias. Blood 84: 4038
Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WH (1994) Silencing of VHL tumour suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 91: 9700
Herman JG, Merlo A, Mao L, Lapidus RG, Issa JJ, Davidson NE, Sidransky D, Baylin SB (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525
Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW, Volgestein B (1994) Deletions of p16 and p15 genes in brain tumours. Cancer Res 54: 6353
Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS3rd, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumour types. Science 264: 436
Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Fong KM, Sekido Y, Hinna JD, Hong WK, Mao L (1997) Identification of three distinct tumour suppresser loci on the short arm of chromosome 9 in small cell lung cancer. Cancer Res 57: 400
Ligget WHJr, Sidransky D (1998) Role of the p16 tumour suppressor gene in cancer. J Clin Oncol 16: 1197
Maelandsmo GM, Berner JM, Florenes VA, Forus A, Hovig E, Fodstad O, Myklebost O (1995) Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas. Relationship to amplification and mRNA levels of CDK4 and CCND1. Br J Cancer 72: 393
Maesawa C, Tamura G, Nishizuka S, Ogasawara S, Ishida K, Terashima M, Sakata K, Sato N, Saito K, Satodate R (1996) Inactivation of the CDKN2 gene by homozygous deletion and the novo methylation is associated with advanced stage oesophageal squamous cell carcinoma. Cancer Res 56: 3875
Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995). 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16 CDKN2/MTS-1 in human cancers. Nat Med 1: 686
Morita R, Ishikawa J, Tsutsumi M, Hikiti K, Tsukeda Y, Kamidono S, Maeda S, Nakamura Y (1991) Allelotype of renal cell carcinoma. Cancer Res 51: 820
Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CL, Croce CM (1994) Rarity of somatic and germ line mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res 54: 5269
Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilton TC, Golwin AK (1995) Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance of 9q and rare alterations involving 9p including CDKN2. Cancer Res 55: 2150
Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richards W, Sugarbaker DJ, Rollins BJ (1995) Reciprocal Rb inactivation and p16 INK4a expression in primary lung cancers and cell lines. Cancer Res 55: 505
Thrash-Bingham CA, Greenberg RE, Howard S, Bruzel A, Bremer M, Goll A, Salazar M, Freed JJ, Tartof KD (1995) Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. Proc Natl Acad Sci U S A 92: 2854
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sanz-Casla, M.T., Maestro, M.L., del Barco, V. et al. Loss of heterozygosity and methylation of p16 in renal cell carcinoma. Urol Res 31, 159–162 (2003). https://doi.org/10.1007/s00240-003-0308-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-003-0308-3